Drug Trial Radar · NCT02919761
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Mar 31, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
259
Actual
Start
Nov 7, 2016
Primary completion
Oct 17, 2018
Study completion Feb 13, 2019
Sponsor
- Lead sponsor
- MallinckrodtIndustry
- Sponsor type
- Industry
- First posted
- Sep 29, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 2-part study to examine the effect of Acthar Gel in adult participants with rheumatoid arthritis (RA) with persistently active disease even after receiving two other treatments intended to modify the disease. Part 1 is an Open Label Period in which all eligible participants receive Acthar Gel for 12 weeks. After these 12 weeks of treatment with Acthar Gel, participants will be evaluated for treatment response using the DAS28-ESR. Participants who have achieved low disease activity (LDA) will enter a double-blind randomized maintenance period (Part 2) and be randomized in a 1:1 ratio to receive either Acthar Gel or matching placebo for an additional 12 weeks. A single participant might be involved in the trial for as many as 32 weeks.
Conditions
- Arthritis, Rheumatoid
Interventions
Acthar GelDrug
80 Units Acthar Gel per 1 mL for subcutaneous injection
PlaceboDrug
Matching placebo 1 mL for subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Number of Participants With Low Disease Activity (LDA) by VisitTime frame: Baseline to Week 12
- Part 2: Number of Participants Who Maintained Low Disease Activity by VisitTime frame: Week 12 to Week 24
Locations
59 sites in 5 countries. Site status is shown where the registry gives one.
East Bay Rheumatology Medical Group
San Leandro, California
Inland Rheumatology Clinical Trials
Upland, California
Orthopedic Research Institute
Boynton Beach, Florida
Clinical Research of West Florida
Clearwater, Florida
Southeastern Integrated Medical, PL, d/b/a Florida Medical Research
Gainesville, Florida
Indago Research and Health Center
Hialeah, Florida
Homestead Associates in Research
Homestead, Florida
Pharmax Research Clinic
Miami, Florida
Suncoast Research Group, LLC
Miami, Florida
San Marcus Research Clinic
Miami Lakes, Florida
Suncoast Clinical Research
New Port Richey, Florida
Omega Research Consultants-DeBary
Orlando, Florida
Millennium Research
Ormond Beach, Florida
Clinical Research of West Florida
Tampa, Florida
Arthritis & Rheumatology of Georgia, PC
Atlanta, Georgia
Arthritis Research and Treatment Center
Stockbridge, Georgia
Arthritis and Diabetes Clinic, Inc.
Monroe, Louisiana
June DO, PC
Lansing, Michigan
Physician Research Collaboration, LLC
Lincoln, Nebraska
DJL Clinical Research
Charlotte, North Carolina
Columbia Arthritis Center
Columbia, South Carolina
West Tennessee Research Institute
Jackson, Tennessee
Ramesh C. Gupta, MD
Memphis, Tennessee
Northwest Med Care
Cypress, Texas
Rheumatic Disease Clinical Research Center
Houston, Texas
Accurate Clinical Research
Houston, Texas
Laila Hassan, MD, PA
Houston, Texas
Pioneer Research Solutions
Houston, Texas
Southwest Rheumatology Research
Mesquite, Texas
Sun Research Institute
San Antonio, Texas
Centro Polivalente de Asistencia e Investigación Clínica CER San Juan
San Juan, Argentina
Aprillus Asistencia e Investigación
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
DIM Clínica Privada
Ramos Mejía, Buenos Aires, Argentina
Centro de Investigaciones Reumatológicas
San Miguel de Tucumán, Tucumán Province, Argentina
Instituto de Investigaciones Aplicadas a la Neurociencia A.C.
Durango, Mexico
Phylasis Clinicas Research S de RL de CV
Estado de México, Mexico
SMIQ
Querétaro, Mexico
Centro de Atención e Investigación Cardiovascular del Potosí, S.C.
San Luis Potosí City, Mexico
INBIOMEDYC Toluca
Toluca, Mexico
Unidad de Enfermedades Reumaticas y Cronico Degenerativas
Torreón, Mexico
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.